Recombinant Listeria monocytogenes serotype 4b Molybdenum cofactor biosynthesis protein A (moaA)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Listeria monocytogenes Serotype 4b Molybdenum Cofactor Biosynthesis Protein A (moaA)

The recombinant Listeria monocytogenes serotype 4b Molybdenum cofactor biosynthesis protein A (moaA) is a protein involved in the biosynthesis of the molybdenum cofactor (Moco), which is essential for various enzymatic reactions in bacteria, including Listeria monocytogenes. This bacterium is a significant foodborne pathogen known for causing listeriosis, a serious infection that can be fatal, especially in vulnerable populations such as the elderly, pregnant women, and individuals with weakened immune systems .

Role of moaA in Molybdenum Cofactor Biosynthesis

Molybdenum cofactor biosynthesis involves several enzymes, with moaA playing a crucial role. It is responsible for converting guanosine 5'-triphosphate (GTP) into 3',8-cyclo-7,8-dihydro-guanosine 5'-triphosphate (3',8-cH2GTP), which is then further processed by moaC to form the pyranopterin backbone of Moco . This process is critical for the survival and pathogenicity of Listeria monocytogenes, as Moco is required for the activity of various enzymes involved in metabolic pathways.

Characteristics of Recombinant moaA Protein

The recombinant moaA protein from Listeria monocytogenes serotype 4b is typically produced through genetic engineering techniques, where the gene encoding moaA is cloned into an expression vector and expressed in a suitable host organism. This allows for the large-scale production of the protein for research purposes.

CharacteristicDescription
FunctionInvolved in the conversion of GTP to 3',8-cH2GTP in Moco biosynthesis.
Expression SystemTypically expressed in bacterial systems like E. coli.
ApplicationsResearch into bacterial pathogenesis and Moco biosynthesis.

Research Findings and Implications

Research on the moaA protein has provided insights into the mechanisms of Moco biosynthesis and its importance in bacterial metabolism. Studies have shown that moaA is essential for the initial steps of Moco formation, and its dysfunction can lead to impaired bacterial growth and virulence .

Pathogenicity and Virulence

Listeria monocytogenes serotype 4b is particularly virulent and responsible for a significant proportion of listeriosis cases. The ability of this bacterium to replicate within host cells, such as monocytes/macrophages, contributes to its pathogenicity . Understanding the role of moaA in maintaining bacterial metabolic functions could provide new targets for therapeutic interventions.

Diagnostic and Therapeutic Potential

While moaA itself is not directly used as a diagnostic or therapeutic target, research into its function and the broader context of Moco biosynthesis could lead to novel strategies for detecting or combating bacterial infections. For instance, inhibiting Moco biosynthesis could potentially impair bacterial growth and virulence.

References

  1. Listeria monocytogenes serotype 4b strains replicate in monocytes/macrophages more than other serotypes .

  2. Iron-Dependent Regulation of Molybdenum Cofactor Biosynthesis .

  3. Monoclonal Antibodies Recognizing the Surface Autolysin IspC of Listeria monocytogenes Serotype 4b .

  4. Recombinant Listeria Monocytogenes Serotype 4b LMOf2365_2298 Protein .

  5. Recombinant Listeria monocytogenes serotype 4b Molybdenum cofactor biosynthesis protein A (moaA) .

  6. Mechanism of pyranopterin ring formation in molybdenum cofactor biosynthesis .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and can be used as a reference.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
moaA; LMOf2365_1068; GTP 3',8-cyclase; EC 4.1.99.22; Molybdenum cofactor biosynthesis protein A
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-333
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Listeria monocytogenes serotype 4b (strain F2365)
Target Names
moaA
Target Protein Sequence
MQLLKDKFGR VHDYIRISVT DRCNLRCVYC MPEEGLTFLP HEKVLSKDEI VSFMELMVKF GIKKVRITGG EPLLRTDIVE IVRGLGAIPE IEDISITTNA MYLAKKAEAL KDAGLTRVNI SLDSLHEDRF KAITRGGRLQ KVLDGIQKAE EVGLFPIKLN VVLIKGQNDD EITDFLRFTK DKDINIRFIE YMPIGHAGTS WKEKYLPLDT IFEACNEAGY EYEPVDSIRG NGPSENFRIK GAKGTFGVIH PVSAHFCDSC NRLRLTADGY IKACLYWDEE MNIRPFIQDP VKLMQLVQKA IDNKPENHEM ALKLQDEVQS NKPTWRRMSQ IGG
Uniprot No.

Target Background

Function
Catalyzes the cyclization of GTP to (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-triphosphate.
Database Links
Protein Families
Radical SAM superfamily, MoaA family

Q&A

What distinguishes Listeria monocytogenes serotype 4b from other serotypes?

Listeria monocytogenes serotype 4b represents one of the most clinically significant serotypes, particularly associated with foodborne outbreaks. Genetically, serotype 4b strains can be distinguished from other serotypes through molecular techniques such as PCR targeting specific genomic regions. Most notably, authentic serotype 4b strains react positively with the serotype 4b-, 4d-, and 4e-specific ORF2110 primers, which serves as a key molecular marker for identification . Additionally, serotype 4b strains typically belong to lineage I, though exceptions exist with some serotype 4b strains surprisingly categorized in lineage III, which represents an important taxonomic distinction for researchers . These lineage III serotype 4b strains demonstrate notable genetic differences, including negative reactions with ORF2110 and lmo1134 primers, suggesting greater genetic complexity within this seemingly homogeneous serotype .

What are the key virulence factors in Listeria monocytogenes serotype 4b?

The virulence profile of L. monocytogenes serotype 4b involves multiple genetic determinants that can be identified through molecular characterization. Research indicates that virulence-specific genes such as lmo2821 and lmo1134 play significant roles in pathogenicity, with most serotype 4b strains in lineage I testing positive for these markers . The prfA virulence gene cluster serves as an important phylogenetic marker and contributes to differential virulence between lineages . While the search results don't explicitly detail all virulence mechanisms, the presence of these genetic markers in serotype 4b strains correlates with their enhanced pathogenicity and frequent association with severe listeriosis outbreaks . Methodologically, researchers should employ both PCR and Southern blot hybridization techniques to fully characterize the virulence gene profile when working with novel serotype 4b isolates .

How do environmental stress adaptations affect Listeria monocytogenes serotype 4b survival?

Listeria monocytogenes, including serotype 4b strains, demonstrates remarkable environmental adaptability through multiple mechanisms. These bacteria can survive and grow across a broad temperature range (-0.4°C to 45°C), making them particularly problematic in refrigerated food systems . When exposed to acidic conditions, L. monocytogenes employs the glutamate decarboxylase (GAD) system, encoded by five genes (gadD1, gadD2, gadD3, gadT1, and gadT2) organized in three genetic loci, to maintain intracellular pH homeostasis . The bacterium also displays tolerance to low water activity environments (aw < 0.90), broad pH ranges (4.6-9.5), and high salt concentrations (up to 20%), enhancing its persistence in food production facilities . Researchers investigating recombinant protein expression should consider these stress response mechanisms, as they may affect protein expression patterns and functional characteristics under various experimental conditions .

What is the structure and function of MoaA in bacterial systems?

MoaA is a critical enzyme in the molybdenum cofactor biosynthesis pathway, belonging to the S-adenosylmethionine (SAM)-dependent radical enzyme superfamily. Structurally, MoaA forms a homodimer with each subunit featuring an incomplete triosephosphate isomerase barrel core formed by the N-terminal portion of the protein . This region contains a characteristic [4Fe-4S] cluster that interacts with SAM, where SAM binds to the unique Fe as an N/O chelate . Distinctively, MoaA contains a second [4Fe-4S] cluster in its C-terminal domain, which is a unique feature of MoaA proteins not found in other SAM-dependent radical enzymes . Both Fe-S clusters are separated by approximately 17 angstroms, creating a large active site pocket between them . Functionally, MoaA works in concert with MoaC to catalyze the first step of molybdenum cofactor biosynthesis, converting 5'-GTP to precursor Z . The non-cysteinyl-ligated unique Fe site of the C-terminal [4Fe-4S] cluster is proposed to be involved in the binding and activation of 5'-GTP .

How does crystal structure analysis inform our understanding of MoaA catalytic mechanism?

Crystal structure analysis has provided crucial insights into the catalytic mechanism of MoaA. The protein has been crystallized and analyzed in both apo-state (2.8 angstroms) and in complex with SAM (2.2 angstroms), revealing important structural details . The central reaction in MoaA activity involves the reductive cleavage of SAM by the N-terminal [4Fe-4S] cluster, generating protein and/or substrate radicals . The unique architecture of MoaA, with two separate [4Fe-4S] clusters creating a large active site pocket, suggests a specialized mechanism for substrate binding and activation . Specifically, the non-cysteinyl-ligated unique Fe site of the C-terminal [4Fe-4S] cluster appears positioned to interact with the substrate 5'-GTP . This structural arrangement facilitates the conversion of 5'-GTP to precursor Z in the initial step of molybdenum cofactor biosynthesis . For researchers examining recombinant MoaA, these structural insights provide a foundation for experimental design, particularly when investigating substrate specificity, enzyme kinetics, or potential inhibition strategies.

What PCR-based methods effectively differentiate Listeria monocytogenes serotype 4b from other serotypes?

A systematic approach to PCR-based serotyping of L. monocytogenes has been established that effectively differentiates serotype 4b from other serotypes. This methodology involves a multiplex PCR approach using several primer sets targeting specific genetic markers . The serotype 4b-, 4d-, and 4e-specific ORF2110 primer set is particularly useful for identifying serotype 4b strains with high specificity . For comprehensive serotype identification, researchers should employ a combined approach using multiple primer sets that can classify L. monocytogenes strains into five serotype groups: 1/2a(3a), 1/2b, 1/2c(3c), 4b(d,e), and 4a/c . Importantly, lineage determination should also be performed, as serotype 4b strains can belong to either lineage I or lineage III, with lineage III strains showing distinct PCR profiles . When applying these methods, researchers should include appropriate positive and negative controls to ensure reliability, with the reported sensitivity for these assays reaching 100% and specificity of approximately 92% for certain primer sets .

How can Southern blot hybridization complement PCR in characterizing Listeria monocytogenes serotype 4b strains?

Southern blot hybridization provides a complementary approach to PCR for the definitive characterization of L. monocytogenes serotype 4b strains. This technique offers confirmation of PCR results and can detect genetic variations that might be missed by PCR alone . When implementing Southern hybridization, researchers should use species-specific probes like lmo0733, which detects all L. monocytogenes strains, and virulence-specific probes such as lmo2821, which identifies most L. monocytogenes strains except serotype 4a and certain lineage III serotype 4b strains . The resulting hybridization patterns can reveal significant genetic differences between lineage I and lineage III serotype 4b strains, with distinctive band sizes observed (typically 5.0-kb bands for most strains, while some lineage III strains show 4.0-, 2.0-, 1.5-, and/or 1.0-kb bands) . This methodological approach provides higher resolution genetic characterization and can uncover relationships between serotype 4b lineage III strains and serotypes 4a and 4c that may not be evident through PCR alone .

What methods should be employed to assess antibiotic resistance profiles in Listeria monocytogenes serotype 4b?

Antimicrobial resistance testing for L. monocytogenes serotype 4b requires a comprehensive approach that evaluates resistance against clinically relevant antibiotics. Current research indicates high levels of resistance to β-lactams (92.94%), oxacillin (88.48%), fosfomycin (85.87%), and flumenique (78.44%), while resistance to gentamycin remains relatively low (1.49%) . When conducting antimicrobial susceptibility testing, researchers should follow standardized protocols such as the disk diffusion method or broth microdilution to ensure reproducibility and comparability of results . Analysis should categorize strains as susceptible, intermediate, or resistant based on established breakpoints, with particular attention to identifying multidrug-resistant strains (MDR), which represent 87.36% of isolated strains in recent studies . Additionally, researchers should consider correlating resistance profiles with serotype and lineage information, as resistance patterns may vary between different genetic backgrounds of serotype 4b strains .

What expression systems are optimal for recombinant MoaA production from Listeria monocytogenes serotype 4b?

The expression of recombinant MoaA from L. monocytogenes serotype 4b requires careful consideration of expression systems that can accommodate the protein's complex structural requirements, particularly its two [4Fe-4S] clusters. Based on successful approaches with similar proteins, E. coli expression systems using vectors such as pET or pBAD series under anaerobic conditions represent viable options for maintaining the integrity of iron-sulfur clusters . Methodologically, researchers should co-express iron-sulfur cluster assembly proteins (such as the isc or suf operons) to enhance proper cluster formation. Culture media should be supplemented with iron and sulfur sources (ferric ammonium citrate and cysteine) to facilitate Fe-S cluster assembly. Expression should be conducted at lower temperatures (16-20°C) to promote proper protein folding and reduce inclusion body formation. Post-expression, all purification steps should be performed under strictly anaerobic conditions using buffers containing reducing agents like dithiothreitol (DTT) or β-mercaptoethanol to preserve the Fe-S clusters essential for MoaA function .

How should researchers approach the purification and stability assessment of recombinant MoaA protein?

Purification of recombinant MoaA requires specialized techniques to maintain the integrity of its two [4Fe-4S] clusters. A multi-step purification strategy should begin with affinity chromatography (typically His-tag based) conducted under strictly anaerobic conditions . All buffers should contain reducing agents (5-10 mM DTT or β-mercaptoethanol) and should be thoroughly degassed before use. Following initial purification, researchers should implement ion exchange chromatography as a secondary purification step to remove contaminants. Stability assessment should include monitoring of the characteristic brown color associated with Fe-S clusters and UV-visible spectroscopy to observe the characteristic absorption peaks of [4Fe-4S] clusters (typically around 410 nm). Electron paramagnetic resonance (EPR) spectroscopy provides a more definitive characterization of the redox state and integrity of the Fe-S clusters. Thermal shift assays can determine protein stability across different buffer conditions, with optimal buffer compositions typically containing glycerol (10-15%) to enhance protein stability during storage. Long-term storage should be at -80°C under anaerobic conditions, with flash-freezing in liquid nitrogen to preserve structural integrity .

What approaches can elucidate the role of MoaA in Listeria monocytogenes serotype 4b virulence?

Investigating the role of MoaA in L. monocytogenes serotype 4b virulence requires a multifaceted approach that connects molybdenum cofactor biosynthesis to pathogenicity. Researchers should begin by generating a moaA deletion mutant in serotype 4b using allelic exchange techniques, followed by complementation studies to confirm phenotypic changes are directly attributable to MoaA . Comparative virulence assessment can be conducted using cell culture infection models with human intestinal epithelial cells and macrophages, measuring bacterial adhesion, invasion, and intracellular replication . In vivo virulence can be evaluated using appropriate animal models, with bacterial burden quantification in target organs such as liver and spleen. Transcriptomic analysis (RNA-Seq) comparing wild-type and ΔmoaA strains under infection-relevant conditions can identify downstream genes affected by molybdenum cofactor availability. Metabolomic profiling can reveal alterations in metabolic pathways dependent on molybdenum cofactor-containing enzymes. Since molybdenum cofactors are utilized by enzymes involved in various metabolic processes, researchers should investigate connections between MoaA function and stress response mechanisms that contribute to L. monocytogenes environmental persistence and virulence .

How can structural biology approaches advance our understanding of MoaA inhibition for potential therapeutic development?

Structural biology offers powerful tools for developing inhibitors against MoaA as potential therapeutics for L. monocytogenes infections. X-ray crystallography should be employed to obtain high-resolution structures of MoaA in complex with substrate analogs or potential inhibitors, building upon existing structural data (2.2-2.8 Å resolution) . Structure-based virtual screening can identify potential inhibitors by computationally docking compound libraries against the active site pocket located between the two [4Fe-4S] clusters. Fragment-based drug discovery approaches can identify small molecular fragments that bind to different regions of the active site, which can then be linked to create more potent inhibitors. Surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC) should be used to quantify binding affinities of potential inhibitors. Enzyme inhibition assays measuring MoaA catalytic activity in the presence of candidate inhibitors can confirm functional impact. The most promising inhibitors should be evaluated for antimicrobial activity against L. monocytogenes serotype 4b, with particular attention to effects on strains exhibiting antibiotic resistance . Selectivity should be assessed by comparing inhibition of bacterial MoaA versus the human ortholog to minimize potential side effects in therapeutic applications .

What environmental parameters should be controlled when studying the expression of recombinant MoaA in Listeria monocytogenes serotype 4b?

When investigating recombinant MoaA expression in L. monocytogenes serotype 4b, researchers must account for this pathogen's remarkable environmental adaptability. Temperature regulation is critical, as L. monocytogenes grows across a wide range (-0.4°C to 45°C) with optimal growth at 37°C . Experimental designs should include temperature conditions that reflect both optimal growth (37°C) and stress conditions (4°C, 42°C) to examine temperature-dependent expression patterns. The pH of culture media should be carefully controlled, with experiments conducted at both neutral pH (7.0) and stress-relevant acidic conditions (pH 5.0-5.5) to assess expression under acid stress . Salt concentration represents another important variable, with media containing 0.5% NaCl (standard) and 10% NaCl (stress condition) to evaluate expression under osmotic stress . Oxygen availability should be modulated through aerobic, microaerobic, and anaerobic cultivation to determine optimal conditions for functional expression of MoaA with intact Fe-S clusters . Growth phase sampling should include exponential and stationary phases, as expression patterns may vary significantly between these states. These controlled environmental parameters enable systematic characterization of recombinant MoaA expression under conditions relevant to both laboratory research and food production environments where L. monocytogenes persists .

How can researchers design experiments to investigate potential cross-talk between MoaA function and antimicrobial resistance in Listeria monocytogenes serotype 4b?

Investigating potential connections between MoaA function and antimicrobial resistance requires carefully designed experiments that integrate genetic manipulation, phenotypic characterization, and molecular analysis. Researchers should begin by generating a set of isogenic strains: wild-type, ΔmoaA mutant, and complemented strains in a serotype 4b background . Antimicrobial susceptibility testing should be performed against clinically relevant antibiotics, particularly β-lactams, oxacillin, fosfomycin, and flumenique, which show high resistance rates in L. monocytogenes . Minimum inhibitory concentration (MIC) determination using broth microdilution or E-test methods should be conducted under standardized conditions. Time-kill assays can provide detailed kinetics of bacterial response to antibiotics. Biofilm formation capacity should be quantified for all strains, as biofilms contribute to antimicrobial resistance and environmental persistence . Gene expression analysis using qRT-PCR should target known antibiotic resistance genes in the presence and absence of functional MoaA to identify potential regulatory relationships. Metabolomic profiling can reveal alterations in metabolic pathways that might contribute to resistance phenotypes. These comprehensive approaches can uncover potential functional links between molybdenum cofactor-dependent processes and antimicrobial resistance mechanisms in this important foodborne pathogen .

What experimental approaches can address data contradictions regarding lineage classification of Listeria monocytogenes serotype 4b strains?

Resolving contradictions in lineage classification of L. monocytogenes serotype 4b strains requires a multi-method approach that integrates genomic, phenotypic, and phylogenetic analyses. Whole genome sequencing represents the gold standard approach, providing complete genetic information for definitive lineage assignment and revealing potential recombination events that may explain taxonomic contradictions . Comparative genomic analysis should focus on identifying lineage-specific genetic markers, particularly those differing between lineage I and lineage III serotype 4b strains. Multi-locus sequence typing (MLST) targeting 7-8 housekeeping genes provides a standardized approach for lineage determination that can be compared across laboratories . PCR-based methods targeting lineage-specific markers, including virulence genes (lmo1134, lmo2821) and serotype-specific regions (ORF2110), should be performed with appropriate controls for each lineage . Southern blot hybridization provides confirmatory evidence of genetic differences between lineages . Phenotypic characterization including virulence assays in cell culture and animal models can determine if lineage differences correlate with pathogenicity. These complementary approaches provide multiple lines of evidence to resolve contradictions in lineage classification, which has important implications for understanding the evolutionary history and pathogenic potential of serotype 4b strains .

How should researchers interpret conflicting data regarding the role of MoaA in stress response and virulence?

When facing contradictory findings regarding MoaA's role in stress response and virulence, researchers should implement a systematic approach to data interpretation. First, conduct a careful assessment of methodological differences between studies, including strain backgrounds (lineage I vs. lineage III serotype 4b), growth conditions, and experimental models . Perform meta-analysis of available data, weighting results based on methodological rigor and sample sizes. Design definitive experiments addressing specific contradictions, with appropriate controls and replication to provide statistical power. Consider genetic complementation experiments to conclusively demonstrate phenotype restoration, ruling out polar effects or secondary mutations . Examine potential strain-specific effects by testing multiple serotype 4b isolates from different lineages under identical conditions . Investigate context-dependent phenotypes by varying environmental parameters relevant to L. monocytogenes lifecycle (temperature, pH, oxygen limitation) . Perform transcriptomic and proteomic analysis under controlled conditions to identify potential compensatory mechanisms that might explain phenotypic differences between studies. This comprehensive approach facilitates interpretation of apparently conflicting data, potentially revealing nuanced relationships between MoaA function and L. monocytogenes pathophysiology that depend on specific genetic backgrounds or environmental conditions .

How might single-cell techniques advance our understanding of heterogeneity in MoaA expression within Listeria monocytogenes serotype 4b populations?

Single-cell analysis technologies offer unprecedented opportunities to investigate population heterogeneity in MoaA expression that may influence L. monocytogenes serotype 4b pathogenicity and stress response. Single-cell RNA sequencing (scRNA-seq) can reveal transcriptional heterogeneity of moaA and associated genes within bacterial populations under various environmental conditions . Reporter fusion systems using fluorescent proteins linked to the moaA promoter, combined with flow cytometry or time-lapse microscopy, can track expression dynamics at single-cell resolution. Single-cell proteomics using mass cytometry (CyTOF) with metal-labeled antibodies against MoaA can quantify protein-level heterogeneity. Microfluidic devices enable long-term tracking of individual bacterial cells, revealing how MoaA expression correlates with growth rate, division patterns, and stress resistance. Single-cell phenotypic analysis using bacterial cytometry can correlate MoaA expression with functional characteristics such as antibiotic susceptibility . These approaches can reveal whether subpopulations with differential MoaA expression exist within serotype 4b populations, potentially explaining phenotypic heterogeneity in virulence or environmental persistence that cannot be detected with population-level analyses .

What are the prospects for developing MoaA-based vaccines against Listeria monocytogenes serotype 4b?

Developing MoaA-based vaccines against L. monocytogenes serotype 4b represents a novel approach that targets a metabolically essential protein. Recombinant MoaA protein vaccine candidates can be designed based on structural insights, focusing on immunogenic epitopes while avoiding regions with homology to human proteins . Attenuated L. monocytogenes serotype 4b strains with modified MoaA expression could serve as live vaccine vectors, potentially offering protection through both humoral and cell-mediated immunity . DNA vaccines encoding MoaA represent another approach, particularly if the protein proves difficult to express in recombinant systems while maintaining proper conformation . Immunoinformatic analysis should be performed to identify T-cell and B-cell epitopes within MoaA that are conserved across L. monocytogenes strains but divergent from human proteins. Vaccine formulation should include appropriate adjuvants to enhance immunogenicity while maintaining safety profiles. Preclinical testing in animal models must assess both protective efficacy against L. monocytogenes challenge and safety, particularly given the essential role of molybdenum cofactor in human metabolism . Cross-protection against different serotypes should be evaluated, as an ideal vaccine would protect against multiple clinically relevant L. monocytogenes strains .

How might comparative analysis of MoaA across different Listeria monocytogenes lineages inform evolutionary adaptation of this pathogen?

Comparative analysis of MoaA across different L. monocytogenes lineages can provide insights into the evolutionary adaptation of this pathogen to diverse ecological niches. Researchers should perform phylogenetic analysis of moaA gene sequences from multiple lineages (I, II, and III) and serotypes, including the divergent serotype 4b strains found in lineage III . Evolutionary rate analysis can identify whether moaA is under purifying selection (indicating functional conservation) or positive selection (suggesting adaptive evolution). Structural bioinformatics approaches can map sequence variations onto the protein structure to identify whether polymorphisms affect catalytic sites, Fe-S cluster coordination, or protein-protein interaction surfaces . Horizontal gene transfer analysis can detect potential recombination events that might explain the unexpected presence of serotype 4b strains in lineage III . Comparative biochemical characterization of recombinant MoaA from different lineages can reveal functional differences in enzyme kinetics, substrate specificity, or stability under stress conditions . Transcriptional regulation analysis can identify lineage-specific differences in moaA expression patterns that might contribute to niche adaptation. These approaches can reveal how MoaA has evolved as L. monocytogenes adapted to different environmental conditions, potentially contributing to the emergence of highly pathogenic serotype 4b strains with distinct genetic backgrounds .

What strategies can overcome challenges in expressing recombinant MoaA with intact Fe-S clusters?

Expressing recombinant MoaA with functional Fe-S clusters presents significant technical challenges requiring specialized approaches. Researchers should employ anaerobic expression systems using E. coli strains optimized for Fe-S cluster assembly (such as BL21(DE3) co-transformed with pRKISC plasmid containing the isc operon) . Culture media should be supplemented with iron (ferric ammonium citrate, 50-100 μM) and sulfur (L-cysteine, 100-200 μM) sources to ensure adequate precursors for Fe-S cluster assembly. Growth and induction conditions should be optimized with low-temperature induction (16-18°C) for 16-24 hours to promote proper protein folding. Strictly anaerobic conditions must be maintained during cell harvest and all purification steps using specialized equipment such as anaerobic chambers or Schlenk lines. Purification buffers should contain reducing agents (5-10 mM DTT or β-mercaptoethanol) and oxygen scavengers (glucose/glucose oxidase system). UV-visible spectroscopy can monitor the characteristic absorption peaks of [4Fe-4S] clusters (~410 nm) throughout purification to assess cluster integrity. Chemical reconstitution of Fe-S clusters can be performed if cluster loss occurs during purification, using ferric chloride, sodium sulfide, and DTT under anaerobic conditions. These technical approaches enable the production of recombinant MoaA with intact Fe-S clusters essential for functional studies .

How can researchers address the challenges of studying MoaA in the context of Listeria monocytogenes pathogenesis?

Studying MoaA in the context of L. monocytogenes pathogenesis presents unique challenges that require integrated experimental approaches. Genetic manipulation strategies should include construction of conditional moaA mutants using inducible promoters, as complete deletion may be lethal under certain conditions . Cell culture infection models should be developed using relevant human cell lines (intestinal epithelial cells, macrophages, and placental cells) to examine the role of MoaA during different stages of infection . Real-time monitoring systems using luminescent or fluorescent reporters linked to moaA expression can track dynamic regulation during infection. Mass spectrometry-based techniques can identify MoaA protein-protein interactions in a serotype 4b background, potentially revealing connections to virulence mechanisms. In vivo imaging systems using bioluminescent reporters can track infection progression in animal models when comparing wild-type and moaA-modified strains. Metabolomic profiling comparing wild-type and moaA-modified strains can identify metabolic pathways affected by altered molybdenum cofactor availability during infection. Considering L. monocytogenes serotype 4b's particular threat to pregnant women, specialized placental models should be developed to examine potential roles of MoaA in transplacental infection . These approaches enable comprehensive investigation of MoaA's roles in L. monocytogenes pathogenesis despite technical challenges.

What are the most promising directions for therapeutic targeting of MoaA in Listeria monocytogenes serotype 4b?

Targeting MoaA in L. monocytogenes serotype 4b offers several promising therapeutic avenues based on its essential role in molybdenum cofactor biosynthesis. Structure-based drug design approaches should leverage the available crystal structure information to develop small molecule inhibitors targeting the unique active site pocket between the two [4Fe-4S] clusters . High-throughput screening of compound libraries against recombinant MoaA can identify lead compounds with inhibitory activity. Computational approaches including molecular dynamics simulations can model inhibitor interactions with MoaA and predict modifications to improve binding affinity and specificity. Peptide-based inhibitors designed to interfere with protein-protein interactions between MoaA and MoaC represent an alternative approach targeting the first step of molybdenum cofactor biosynthesis . Antisense technologies including peptide nucleic acids (PNAs) can be developed to specifically inhibit moaA gene expression. Combination therapy approaches pairing MoaA inhibitors with conventional antibiotics may enhance efficacy against resistant strains, given the high prevalence of antibiotic resistance in L. monocytogenes . Delivery systems such as nanoparticles could improve the therapeutic potential of MoaA inhibitors by enhancing uptake into bacterial cells. These diverse therapeutic strategies targeting MoaA could lead to novel treatments for L. monocytogenes infections, particularly important given the high mortality rate (20-30%) associated with listeriosis in vulnerable populations .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.